Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Betaxolol adverse reaction |
Causative agent (attribute) |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Allergy to betaxolol |
Causative agent (attribute) |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol HCl [b-blocker] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol hydrochloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol (as betaxolol hydrochloride) 2.5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol 0.25% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol (as betaxolol hydrochloride) 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol hydrochloride 0.25% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol hydrochloride 0.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Betaxolol hydrochloride 2.5mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Ophthalmic betaxolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Allergy to betaxolol |
Causative agent (attribute) |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol hydrochloride 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol hydrochloride 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol (as betaxolol hydrochloride) 2.5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol (as betaxolol hydrochloride) 5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Betaxolol 0.25% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |